Comparison

Multi-kinase inhibitor 1 European Partner

Item no. TMO-T4191-2mg
Manufacturer TargetMol
CASRN 778274-97-8
Amount 2 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 1 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Citations 1.Chang Hsu Y, et al. Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation. Oncotarget. 2016 Nov 15
Smiles N(C1=CC(C2=CC=C(C(NCCO)=O)C=C2)=NC=N1)C3=CC=C(OC(F)(F)F)C=C3
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias Multi-kinase inhibitor I
Shipping Condition Cool pack
Available
Manufacturer - Targets
PDGFR|||c-Kit|||Bcr-Abl
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
418.37
Description
Multi-kinase inhibitor 1 (Multi-kinase inhibitor I) is a Multi-kinase inhibitor.
Pathways
Cytoskeletal Signaling|||Angiogenesis|||Tyrosine Kinase/Adaptors
Bioactivity
Multi-kinase inhibitor I, is a Multi-kinase inhibitor. MDK74978 has CAS#778274-97-8. The last 5 digit was used in its name
Receptor
Multi-kinase

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 2 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close